FOLR1 and endometrial cancer: Boogerd et al. showed that targeting FRα resulted in the detection of all 16 LNMs out of the 22 resected LNs in cases of endometrial cancer, with a mean in vivo TBR of 6.3 (SD-4.5; range 3.2–14.1).